Bases of molecular knowledge of autism with VARS y NRXN1 variants: purpose of a case
DOI:
https://doi.org/10.18041/2665-427X/ijeph.1.8637Keywords:
autistic disorder, neurodevelopmental disorders, genetic testing, NRXN1, VARS, genetic variantsAbstract
Background: Autism spectrum disorder (ASD) comprises heterogeneous alterations that compromise neurodevelopment, mainly the ability to communicate and relate to the environment, and do not resolve at any time in life. It presents with multiple profiles and its clinical expression depends on different factors where genetics and environmental factors play a fundamental role. This is an important group of delayed psychomotor development in the pediatric population and despite not having a curative treatment, early identification will allow an early initiation of neurobehavioral therapies, targeted complementary management and appropriate clinical follow-up, improving the prognosis and offering a Specific genetic counseling, carrying out primary prevention strategies, which will impact the burden of disease. Identifying it early makes it easier to find different genetic associations through tests such as next generation sequencing (NGS), constituting a path to develop future therapies.
Case presentation: The case of a 5-year-old male patient with delayed psychomotor development due to impaired language is described, in whom three variants of the NRXN1 and VARS2 genes associated with ASD were detected through an NGS test, allowing genetic counseling. adequately and guiding the therapy individually.
Results: Using a next-generation sequencing test, three variants of the NRXN1 and VARS2 genes associated with autism spectrum disorder were detected, allowing appropriate genetic counseling, and guiding individualized therapy.
Downloads
References
1. Bonilla MF, Chaskel R. Trastorno del Espectro Autista. Curso Aontínuo de Actualización en Pediatría. 2016; 15(1): 19-29.
2. Augustyn M. Autism spectrum disorder: Terminology, epidemiology, and pathogenesis. Uptodate; 2020.
3. Gauthier J, Siddiqui T, Huashan P, Yokomaku D, Hamdan F, Champagne N, et al. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet. 2011; 130(4): 563–573. doi:10.1007/s00439-011-0975-z
4. Fundación Avante. autismo en Colombia. Fundavante.org. Consultado en: febrero 2021. Disponible en: https://www.fundavante.org/autismo-en-colombia
5. Alsemari A, Al-Younes B, Goljan E, Jaroudi D, Bin Humaid F, Meyer B, et al. Recessive VARS2 mutation underlies a novel syndrome with epilepsy, mental retardation, short stature, growth hormone deficiency, and hypogonadism. Hum Genomics. 2017;11(1):28. doi:10.1186/s40246-017-0124-4
6. Satterstrom K, Kosmicki J, Wang J, Roeder K, Daly M, Buxbaum J. Large-Scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism. Cell. 2020; 180: 1-17. Doi: 10.1016/j.cell.2019.12.036
7. Rubenstein J, Merzenich M. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2003; 2(5): 255-267. doi:10.1034/j.1601-183x.2003.00037.x
8. Upadhyay J, Patra J, Tiwari N, Shankar N, Ansari MN, Ahmad W. Dysregulation of multiple signaling neurodevelopmental pathways during embryogenesis: a possible cause of autism spectrum disorder. Cells. 2021; 10: 958. doi: 10.3390/cells10040958
Downloads
Published
Versions
- 2023-06-22 (3)
- 2023-10-25 (2)
- 2023-03-15 (1)
Issue
Section
License
Copyright (c) 2023 Interdisciplinary Journal of Epidemiology and Public Health
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
